| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | ANK2 RETREG2 TCOF1 KAT6A CAMTA2 SRCAP WNK1 AKAP12 MAPK8IP3 ZZZ3 BRDT TLE1 TLE3 TAX1BP1 SYNE2 RNF20 RETREG1 SMARCC2 MPHOSPH8 TACC1 CAPRIN1 ZNF653 MRTFA HR | 3.32e-05 | 1160 | 166 | 24 | GO:0030674 |
| GeneOntologyMolecularFunction | endoplasmic reticulum-organelle membrane tether activity | 2.05e-04 | 3 | 166 | 2 | GO:0170009 | |
| GeneOntologyMolecularFunction | endoplasmic reticulum-autophagosome adaptor activity | 2.05e-04 | 3 | 166 | 2 | GO:0140506 | |
| GeneOntologyMolecularFunction | autophagosome-membrane adaptor activity | 2.05e-04 | 3 | 166 | 2 | GO:0160183 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | ANK2 RETREG2 TCOF1 KAT6A CAMTA2 SRCAP WNK1 AKAP12 MAPK8IP3 ZZZ3 BRDT TLE1 TLE3 TAX1BP1 SYNE2 RNF20 RETREG1 SMARCC2 MPHOSPH8 TACC1 CAPRIN1 ZNF653 MRTFA HR | 3.60e-04 | 1356 | 166 | 24 | GO:0060090 |
| GeneOntologyMolecularFunction | histone binding | 3.86e-04 | 265 | 166 | 9 | GO:0042393 | |
| GeneOntologyMolecularFunction | histone modifying activity | 6.76e-04 | 229 | 166 | 8 | GO:0140993 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 8.49e-04 | 51 | 166 | 4 | GO:0004402 | |
| HumanPheno | Abnormal 5th finger morphology | MIA3 RPGRIP1L SRCAP MAPK8IP3 TWIST1 LIFR BMP2 GTF2I TXNDC15 CEP120 BRCA2 BUB1 ANKRD11 PACS2 SMARCC2 PRKCZ CAPRIN1 VPS13B | 2.05e-05 | 509 | 62 | 18 | HP:0004207 |
| HumanPheno | Abnormal cheek morphology | RPGRIP1L TCOF1 PCLO KAT6A NEK9 MAPK8IP3 LIFR BMP2 KIDINS220 TXNDC15 TECPR2 ANKRD11 VPS13B | 2.49e-05 | 282 | 62 | 13 | HP:0004426 |
| Domain | Reticulon | 2.15e-05 | 7 | 161 | 3 | PF02453 | |
| Domain | Reticulon | 3.41e-05 | 8 | 161 | 3 | IPR003388 | |
| Domain | TECPR | 2.20e-04 | 3 | 161 | 2 | SM00706 | |
| Domain | TACC | 2.20e-04 | 3 | 161 | 2 | PF05010 | |
| Domain | Beta-propeller_rpt_TECPR | 2.20e-04 | 3 | 161 | 2 | IPR006624 | |
| Domain | TACC | 2.20e-04 | 3 | 161 | 2 | IPR007707 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ROCK2 TCOF1 SF3A1 USP24 MYO18A DIDO1 SMARCAD1 ITPRID2 MAPK8IP3 TRIM16 SCAF1 GTF2I TLE3 ASPH RNF20 ZNF638 PACS2 SMARCC2 CCAR2 CTNNA1 PROSER2 SRRM2 ZHX1 MRTFA MYBL2 | 8.05e-14 | 774 | 169 | 25 | 15302935 |
| Pubmed | MIA3 ANK2 TCOF1 RPAP3 SF3A1 MYO18A PSMC4 RTN3 SMARCAD1 ITPRID2 KANK2 GTF3C3 AKAP12 LIFR UBE4A KIDINS220 INF2 CDC123 SYNE2 ASPH RETREG1 ANKRD11 MACF1 TMEM131 TACC1 CTNNA1 DDHD2 HERC2 EIF4G3 SRRM2 CAPRIN1 AP3D1 VPS13B | 2.27e-13 | 1487 | 169 | 33 | 33957083 | |
| Pubmed | ROCK2 MIA3 ANK2 LZTS3 DSCAM TCOF1 USP28 KIF21A DIDO1 KANK2 NEK9 AKAP12 MAPK8IP3 NCAN TAX1BP1 SYNE2 SMARCC2 MACF1 CCAR2 CTNNA1 HERC2 UNC79 CAPRIN1 | 3.52e-10 | 963 | 169 | 23 | 28671696 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MBTD1 RPGRIP1L TCOF1 USP28 BAK1 PSMC4 RTN3 TACC2 SMARCAD1 RABGAP1 ITPRID2 SRCAP WNK1 ZZZ3 BRCA2 BUB1 MACF1 MYBL2 | 7.17e-10 | 588 | 169 | 18 | 38580884 |
| Pubmed | SEL1L ROCK2 MIA3 TCOF1 KIF21A USP24 PSMC4 RTN3 DIDO1 SMARCAD1 WNK1 KANK2 ADAR AKAP12 KIDINS220 TXNDC15 CDC123 TAX1BP1 SYNE2 ASPH SMARCC2 MACF1 CCAR2 SRRM2 CAPRIN1 AP3D1 | 9.41e-10 | 1297 | 169 | 26 | 33545068 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOXJ2 FOXO3 MBTD1 USP28 SF3A1 SMARCAD1 E4F1 KANK2 ADAR FOXR2 GTF3C3 TWIST1 ZBTB37 UBE4A SH3TC1 TLE1 TLE3 A2ML1 SMARCC2 CCAR2 MYBL2 | 1.40e-09 | 857 | 169 | 21 | 25609649 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FOXO3 POU6F2 MIA3 KAT6A RTN3 RABGAP1 NEK9 C2CD2 MAPK8IP3 GTF2I KIDINS220 KCNQ5 SH3TC1 TECPR2 INF2 TLE3 ASPH ANKRD11 ZNF638 SDC3 MACF1 RPRD2 PRKCZ EIF4G3 VPS13B VAV2 | 1.61e-08 | 1489 | 169 | 26 | 28611215 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | ROCK2 TCOF1 RPAP3 SF3A1 KIF21A USP24 PSMC4 DIDO1 TACC2 SMARCAD1 WNK1 TRIP10 NEK9 GTF2I SYNE2 ASPH RNF20 ZNF638 SMARCC2 MACF1 CCAR2 CTNNA1 SRRM2 CAPRIN1 AP3D1 | 2.50e-08 | 1415 | 169 | 25 | 28515276 |
| Pubmed | ROCK2 TCOF1 USP24 DIDO1 TACC2 WNK1 ADAR GTF2I TLE3 ZNF638 RPRD2 TMEM131 EIF4G3 SRRM2 MRTFA | 2.84e-08 | 503 | 169 | 15 | 16964243 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ANK2 DSC1 TCOF1 RPAP3 USP28 SF3A1 DIDO1 TACC2 SRCAP WNK1 ADAR NEK9 AKAP12 GTF2I ZNF638 MACF1 RPRD2 TACC1 EIF4G3 AP3D1 | 3.32e-08 | 934 | 169 | 20 | 33916271 |
| Pubmed | TCOF1 SF3A1 USP24 DIDO1 GTF3C3 GTF2I SYNE2 ZNF638 SMARCC2 MACF1 CCAR2 CTNNA1 HERC2 EIF4G3 SRRM2 CAPRIN1 | 1.42e-07 | 653 | 169 | 16 | 22586326 | |
| Pubmed | RPAP3 USP24 RABGAP1 NEK9 GTF3C3 GTF2I ZZZ3 BRCA2 TLE1 TLE3 BUB1 MRTFA MYBL2 | 1.53e-07 | 418 | 169 | 13 | 34709266 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | ROCK2 MIA3 SF3A1 KIF21A PSMC4 RABGAP1 SRCAP WNK1 ADAR TWIST1 GTF2I RNF20 SMARCC2 MACF1 CCAR2 EIF4G3 CAPRIN1 AP3D1 | 1.89e-07 | 847 | 169 | 18 | 35235311 |
| Pubmed | MKRN4P FOXJ2 ZNF777 NR2E3 DIDO1 TACC2 E4F1 ZKSCAN5 DMBX1 TWIST1 TRIM16 GTF2I ZZZ3 ZNF638 MACF1 MYBL2 | 4.27e-07 | 709 | 169 | 16 | 22988430 | |
| Pubmed | Modulation of Tcf3 repressor complex composition regulates cdx4 expression in zebrafish. | 4.49e-07 | 4 | 169 | 3 | 21666599 | |
| Pubmed | MBTD1 MYO18A PSMC4 DIDO1 SRCAP GTF3C3 CHCHD4 GTF2I ZZZ3 TLE1 TLE3 SYNE2 ZNF638 SMARCC2 CCAR2 RPRD2 ELF4 HERC2 SRRM2 TAF1L CAPRIN1 ZHX1 MYBL2 | 4.92e-07 | 1429 | 169 | 23 | 35140242 | |
| Pubmed | USP28 DIDO1 LRCH1 KANK2 ADAR TLE3 MACF1 RPRD2 MPHOSPH8 TACC1 SRRM2 CAPRIN1 MRTFA | 6.06e-07 | 472 | 169 | 13 | 38943005 | |
| Pubmed | PIK3AP1 MIA3 RPGRIP1L RPAP3 PSMC4 NDFIP2 WNK1 KANK2 TLE1 ZNF638 CCAR2 RPRD2 TMEM131 TACC1 PPIP5K2 MYBL2 | 6.61e-07 | 733 | 169 | 16 | 34672954 | |
| Pubmed | TCOF1 SF3A1 PSMC4 WNK1 GTF2I TLE3 SMARCC2 CCAR2 RPRD2 PROSER2 SRRM2 CAPRIN1 | 6.65e-07 | 399 | 169 | 12 | 35987950 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DSC1 RPAP3 KIF21A PSMC4 SMARCAD1 SRCAP ADAR NEK9 GTF3C3 GTF2I INF2 A2ML1 ASPH RNF20 ZNF638 SMARCC2 MACF1 CCAR2 HERC2 SRRM2 CAPRIN1 AP3D1 | 7.55e-07 | 1353 | 169 | 22 | 29467282 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | FOXO3 TCOF1 RPAP3 RTN3 SNX21 MON1A GMIP WNK1 LRCH1 KANK2 NEK9 GTF3C3 RABL6 CDC123 CCAR2 RPRD2 PROSER2 AP3D1 MRTFA | 8.11e-07 | 1038 | 169 | 19 | 26673895 |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | ANK2 TCOF1 SF3A1 DIDO1 ADAR GTF2I ZNF638 SMARCC2 CCAR2 RPRD2 | 9.41e-07 | 271 | 169 | 10 | 32433965 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RETREG2 SF3A1 TACC2 KANK2 NEK9 GTF3C3 AKAP12 CHCHD4 LLGL2 GTF2I CEP120 INF2 BUB1 SMARCC2 CCAR2 CTNNA1 HERC2 CAPRIN1 VPS13B MYBL2 | 9.63e-07 | 1155 | 169 | 20 | 20360068 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MIA3 RPGRIP1L RPAP3 PCLO PSMC4 RTN3 TACC2 RABGAP1 ITPRID2 UBE4A CHCHD4 INF2 SYNE2 BUB1 RETREG1 CCAR2 TMEM131 TACC1 DDHD2 HERC2 SRRM2 CAPRIN1 VPS13B | 1.08e-06 | 1496 | 169 | 23 | 32877691 |
| Pubmed | TCOF1 SF3A1 PSMC4 SRCAP NEK9 GTF2I ZZZ3 INF2 RNF20 SMARCC2 RPRD2 SRRM2 MRTFA | 1.31e-06 | 506 | 169 | 13 | 30890647 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | MBTD1 RNF168 TCOF1 SF3A1 DIDO1 E4F1 SRCAP ADAR SCAF1 GTF2I ZZZ3 ASPH RNF20 ANKRD11 ZNF638 RPRD2 ELF4 MPHOSPH8 SRRM2 TAF1L MYBL2 | 1.42e-06 | 1294 | 169 | 21 | 30804502 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | TCOF1 NDFIP2 SMARCAD1 ITPRID2 MAGEE1 WNK1 NEK9 ZKSCAN5 BUB1 EIF4G3 ZHX1 MRTFA | 1.45e-06 | 430 | 169 | 12 | 35044719 |
| Pubmed | MIA3 TCOF1 DIDO1 AKAP12 TRIM16 RNF20 ZNF638 MACF1 CTNNA1 PPIP5K2 SRRM2 | 1.69e-06 | 360 | 169 | 11 | 33111431 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | MIA3 TCOF1 SRCAP ADAR TRIP10 GTF3C3 GTF2I RNF20 SMARCC2 RPRD2 HERC2 CAPRIN1 | 1.84e-06 | 440 | 169 | 12 | 34244565 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FOXO3 SPEG KAT6A SRCAP RALGAPA2 WNK1 C2CD2 MAPK8IP3 RABL6 SCAF1 LLGL2 SH3TC1 INF2 ANKRD11 HERC2 GGA1 AP3D1 MYBL2 HR | 2.03e-06 | 1105 | 169 | 19 | 35748872 |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 2.14e-06 | 231 | 169 | 9 | 16452087 | |
| Pubmed | ROCK2 ANK2 TCOF1 RPAP3 SF3A1 USP24 PSMC4 AKAP12 RABL6 KIDINS220 MACF1 CTNNA1 EIF4G3 MAP3K21 AP3D1 | 2.16e-06 | 708 | 169 | 15 | 39231216 | |
| Pubmed | 2.23e-06 | 6 | 169 | 3 | 19838196 | ||
| Pubmed | ANK2 TCOF1 PSMC4 NEK9 AKAP12 RABL6 UBE4A KIDINS220 CDC123 TACC1 GGA1 AP3D1 | 2.27e-06 | 449 | 169 | 12 | 31732153 | |
| Pubmed | AMPH MIA3 ANK2 RETREG2 LZTS3 PCLO USP24 MYO18A PSMC4 RTN3 TACC2 RABGAP1 MAPK8IP3 KCNQ5 SMARCC2 MACF1 TACC1 EIF4G3 CAPRIN1 | 3.15e-06 | 1139 | 169 | 19 | 36417873 | |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 3.61e-06 | 130 | 169 | 7 | 35545047 | |
| Pubmed | MIA3 RPAP3 DIDO1 SMARCAD1 GMIP LLGL2 BUB1 ASPH RNF20 ZNF638 METTL16 PPIP5K2 AP3D1 HR | 3.96e-06 | 650 | 169 | 14 | 38777146 | |
| Pubmed | DCHS2 ANK2 DSCAM TCOF1 USP28 KIF21A SMARCAD1 KANK2 ZKSCAN5 MAPK8IP3 UBE4A TXNDC15 RETREG1 MACF1 TMEM131 CTNNA1 HERC2 EIF4G3 ST18 CAPRIN1 | 4.81e-06 | 1285 | 169 | 20 | 35914814 | |
| Pubmed | SPEG SMARCAD1 CAMTA2 KIDINS220 TLE3 PACS2 MACF1 CCAR2 SRRM2 ST18 VPS13B | 5.45e-06 | 407 | 169 | 11 | 12693553 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | SF3A1 PSMC4 DIDO1 SMARCAD1 SRCAP GTF2I RNF20 ZNF638 CCAR2 SRRM2 | 5.74e-06 | 332 | 169 | 10 | 32786267 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | TCOF1 SF3A1 MYO18A DIDO1 SRCAP LRCH1 ADAR GTF3C3 KIDINS220 NRXN2 ZNF638 SMARCC2 MACF1 MPHOSPH8 PPIP5K2 SRRM2 TNXB AP3D1 | 6.04e-06 | 1082 | 169 | 18 | 38697112 |
| Pubmed | MIA3 RABL6 KIDINS220 ZNF638 MACF1 TMEM131 TACC1 AP3D1 VPS13B | 6.14e-06 | 263 | 169 | 9 | 34702444 | |
| Pubmed | TCOF1 SF3A1 DIDO1 ADAR GTF2I ZNF638 SMARCC2 CCAR2 RPRD2 CAPRIN1 | 7.07e-06 | 340 | 169 | 10 | 24332808 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | TCOF1 SF3A1 DIDO1 SMARCAD1 SRCAP TLE3 ZNF638 SMARCC2 SRRM2 AP3D1 | 7.25e-06 | 341 | 169 | 10 | 32971831 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | DSC1 TCOF1 USP28 SF3A1 PSMC4 DIDO1 ADAR GTF3C3 SCAF1 GTF2I RNF20 ZNF638 SMARCC2 CCAR2 MPHOSPH8 SRRM2 CAPRIN1 | 7.28e-06 | 989 | 169 | 17 | 36424410 |
| Pubmed | RTN3 RABGAP1 MON1A RGP1 AKAP12 KIDINS220 INF2 SYNE2 RETREG1 TMEM131 TACC1 VPS13B | 7.33e-06 | 504 | 169 | 12 | 34432599 | |
| Pubmed | SEL1L FOXO3 MBTD1 SF3A1 BAK1 WNK1 TWIST1 C2orf72 TRIM16 C9orf153 UBE4A SCAF1 LLGL2 GTF2I TLE1 RNF20 ANKRD11 MPHOSPH8 METTL16 CAPRIN1 | 7.72e-06 | 1327 | 169 | 20 | 32694731 | |
| Pubmed | Characterization of cDNA clones in size-fractionated cDNA libraries from human brain. | 7.98e-06 | 56 | 169 | 5 | 9455484 | |
| Pubmed | MIA3 RNF168 KANK2 NEK9 GTF3C3 SCAF1 GTF2I TXNDC15 TAX1BP1 BUB1 PRKCZ HERC2 GGA1 | 8.93e-06 | 604 | 169 | 13 | 38803224 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | RNF168 ZNF184 KAT6A DIDO1 SMARCAD1 SRCAP GTF3C3 GTF2I SMARCC2 MPHOSPH8 HERC2 ZHX1 MYBL2 | 9.58e-06 | 608 | 169 | 13 | 36089195 |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | FOXO3 AMPH RETREG2 BAK1 MON1A ZKSCAN5 AKAP12 ZZZ3 NRXN2 INF2 TLE1 SYNE2 PRKCZ CTNNA1 EIF4G3 ZHX1 SEZ6 MYBL2 | 1.01e-05 | 1124 | 169 | 18 | 21900206 |
| Pubmed | MKRN4P FOXJ2 FOXO3 NR2E3 DIDO1 SRCAP DMBX1 ZBTB37 GTF2I BRDT TLE3 ZNF638 ZNF653 MRTFA MYBL2 | 1.05e-05 | 808 | 169 | 15 | 20412781 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 1.08e-05 | 357 | 169 | 10 | 37059091 | |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 1.10e-05 | 154 | 169 | 7 | 16055720 | |
| Pubmed | 1.23e-05 | 104 | 169 | 6 | 9205841 | ||
| Pubmed | 1.37e-05 | 106 | 169 | 6 | 18654987 | ||
| Pubmed | 2.08e-05 | 68 | 169 | 5 | 14676191 | ||
| Pubmed | SEL1L DSC1 TCOF1 MYO18A DIDO1 KANK2 FSCB TRIM16 BRCA2 SYNE2 ZNF638 PROSER2 VAV2 MRTFA | 2.09e-05 | 754 | 169 | 14 | 35906200 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DSC1 TCOF1 SF3A1 PCLO PSMC4 RTN3 NDFIP2 SMARCAD1 ADAR NEK9 GTF3C3 UBE4A SCAF1 GTF2I KIDINS220 RNF20 CCAR2 MPHOSPH8 SRRM2 CAPRIN1 | 2.15e-05 | 1425 | 169 | 20 | 30948266 |
| Pubmed | ROCK2 AMPH ANK2 LZTS3 PCLO MYO18A RTN3 KANK2 MAPK8IP3 KIDINS220 NRXN2 INF2 NCAN PACS2 SMARCC2 MACF1 CTNNA1 EIF4G3 CAPRIN1 AP3D1 | 2.28e-05 | 1431 | 169 | 20 | 37142655 | |
| Pubmed | TCOF1 RPAP3 SF3A1 SRCAP GTF3C3 GTF2I SMARCC2 CCAR2 METTL16 TAF1L | 2.31e-05 | 390 | 169 | 10 | 17643375 | |
| Pubmed | Modulation of ileal apical Na+-dependent bile acid transporter ASBT by protein kinase C. | 2.35e-05 | 2 | 169 | 2 | 19571234 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 24231951 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 31776330 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 20941506 | ||
| Pubmed | Identifying key genes associated with acute myocardial infarction. | 2.35e-05 | 2 | 169 | 2 | 29049183 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 10435627 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 18566367 | ||
| Pubmed | MBTD1 preserves adult hematopoietic stem cell pool size and function. | 2.35e-05 | 2 | 169 | 2 | 37523546 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 34274317 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 10831834 | ||
| Pubmed | Differential functions of TLE1 and TLE3 depending on a specific phosphorylation site. | 2.35e-05 | 2 | 169 | 2 | 33571907 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 32793186 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | ROCK2 FOXO3 RPGRIP1L RPAP3 SF3A1 PSMC4 WNK1 NEK9 AKAP12 GTF2I CEP120 PTPRQ BUB1 ZNF638 CCAR2 CTNNA1 PPIP5K2 MAP3K21 GGA1 | 2.52e-05 | 1321 | 169 | 19 | 27173435 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | ROCK2 SF3A1 KIF21A USP24 PSMC4 SMARCAD1 RABGAP1 WNK1 TRIP10 NEK9 AKAP12 TRIM16 RABL6 GTF2I TLE3 RNF20 MACF1 CCAR2 CTNNA1 AP3D1 | 2.89e-05 | 1455 | 169 | 20 | 22863883 |
| Pubmed | RPGRIP1L DSCAM TCOF1 GTF3C3 AKAP12 RABL6 GTF2I KIDINS220 ZNF638 CCAR2 TACC1 EIF4G3 GGA1 AP3D1 | 2.90e-05 | 777 | 169 | 14 | 35844135 | |
| Pubmed | 2.93e-05 | 246 | 169 | 8 | 15345747 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | ROCK2 SF3A1 KIF21A USP24 PSMC4 SMARCAD1 BUB1 ZNF638 SMARCC2 MACF1 CTNNA1 SRRM2 | 3.03e-05 | 582 | 169 | 12 | 20467437 |
| Pubmed | 3.05e-05 | 322 | 169 | 9 | 26514267 | ||
| Pubmed | 3.11e-05 | 13 | 169 | 3 | 15237213 | ||
| Pubmed | 3.11e-05 | 13 | 169 | 3 | 29499138 | ||
| Pubmed | Cep120 and TACCs control interkinetic nuclear migration and the neural progenitor pool. | 3.11e-05 | 13 | 169 | 3 | 17920017 | |
| Pubmed | Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex. | 3.14e-05 | 37 | 169 | 4 | 27565344 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | FOXJ2 FOXO3 POU6F2 E4F1 CAMTA2 DMBX1 FOXR2 TWIST1 ZZZ3 SKOR1 ELF4 ST18 ZHX1 ZNF653 MYBL2 | 4.04e-05 | 908 | 169 | 15 | 19274049 |
| Pubmed | 4.29e-05 | 40 | 169 | 4 | 28805822 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MIA3 PCLO PSMC4 RTN3 SRCAP LLGL2 RNF20 PACS2 SMARCC2 MACF1 CTNNA1 UNC79 AP3D1 VAV2 | 4.37e-05 | 807 | 169 | 14 | 30575818 |
| Pubmed | ROCK2 RALGAPA2 RGP1 LRCH1 AKAP12 LLGL2 KIDINS220 INF2 MACF1 CTNNA1 | 4.39e-05 | 421 | 169 | 10 | 36976175 | |
| Pubmed | 4.56e-05 | 131 | 169 | 6 | 31006538 | ||
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 5.17e-05 | 134 | 169 | 6 | 25452129 | |
| Pubmed | 5.23e-05 | 267 | 169 | 8 | 33417871 | ||
| Pubmed | 5.45e-05 | 347 | 169 | 9 | 17114649 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | ROCK2 TCOF1 SF3A1 BAK1 PSMC4 NEK9 GTF3C3 UBE4A GTF2I TLE1 TLE3 CCAR2 HERC2 EIF4G3 MAP3K21 SRRM2 UNC79 CAPRIN1 | 5.78e-05 | 1284 | 169 | 18 | 17353931 |
| Pubmed | FOXO3 DSC1 SF3A1 PSMC4 RABGAP1 NEK9 GTF3C3 TECPR2 ASPH CCAR2 | 6.00e-05 | 437 | 169 | 10 | 20562859 | |
| Pubmed | 6.03e-05 | 16 | 169 | 3 | 11013263 | ||
| Pubmed | 6.03e-05 | 16 | 169 | 3 | 30689641 | ||
| Pubmed | ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease. | 6.26e-05 | 202 | 169 | 7 | 33601422 | |
| Pubmed | 6.27e-05 | 274 | 169 | 8 | 34244482 | ||
| Pubmed | 6.84e-05 | 87 | 169 | 5 | 24169447 | ||
| Pubmed | 6.84e-05 | 87 | 169 | 5 | 12465718 | ||
| Pubmed | 7.02e-05 | 3 | 169 | 2 | 27687729 | ||
| Interaction | HDAC1 interactions | RPAP3 SF3A1 USP24 SMARCAD1 E4F1 RABGAP1 NEK9 GTF2I ZZZ3 BRCA2 CDC123 TLE1 TLE3 TAX1BP1 SYNE2 BUB1 RNF20 CHFR SKOR1 ZNF638 SMARCC2 CCAR2 CAPRIN1 ZHX1 MRTFA HR | 1.49e-06 | 1108 | 167 | 26 | int:HDAC1 |
| Interaction | TMT1A interactions | MIA3 PSMC4 RTN3 LIFR KIDINS220 KCNQ5 INF2 CDC123 SYNE2 RETREG1 TMEM131 TACC1 DDHD2 VPS13B | 1.85e-06 | 359 | 167 | 14 | int:TMT1A |
| Interaction | SMARCA4 interactions | SF3A1 KAT6A USP24 MYO18A SMARCAD1 E4F1 SRCAP GTF3C3 RABL6 BRDT TLE3 CHFR SMARCC2 SRRM2 MRTFA | 7.36e-06 | 462 | 167 | 15 | int:SMARCA4 |
| Interaction | CLTA interactions | MIA3 RETREG2 MYO18A WNK1 RABL6 KIDINS220 CDC123 TAX1BP1 HERC2 MAP3K21 GGA1 AP3D1 MYBL2 | 7.63e-06 | 351 | 167 | 13 | int:CLTA |
| Interaction | DNAJC1 interactions | MIA3 RTN3 ITPRID2 TGOLN2 UBE4A KIDINS220 INF2 CDC123 SYNE2 RETREG1 TMEM131 TACC1 SRRM2 | 1.03e-05 | 361 | 167 | 13 | int:DNAJC1 |
| Interaction | NUP43 interactions | DSC1 DSCAM SMARCAD1 ITPRID2 SRCAP SCAF1 GTF2I ZZZ3 BRCA2 SYNE2 ANKRD11 CCAR2 ELF4 EIF4G3 SRRM2 ZHX1 MYBL2 | 1.81e-05 | 625 | 167 | 17 | int:NUP43 |
| Interaction | SYNE3 interactions | SEL1L MIA3 RTN3 ITPRID2 STIL KANK2 KIDINS220 KCNQ5 BRCA2 SYNE2 ASPH MACF1 TMEM131 TACC1 | 2.08e-05 | 444 | 167 | 14 | int:SYNE3 |
| Interaction | STX6 interactions | MAGEA9 MIA3 RABGAP1 GTF3C3 AKAP12 TGOLN2 RABL6 KIDINS220 INF2 ASPH MACF1 TACC1 AP3D1 VPS13B | 2.29e-05 | 448 | 167 | 14 | int:STX6 |
| Interaction | CTR9 interactions | MAGEA9 KAT6A TACC2 NEK9 RABL6 INF2 RNF20 RPRD2 TMEM131 EIF4G3 | 2.55e-05 | 233 | 167 | 10 | int:CTR9 |
| Interaction | TANGO6 interactions | 2.71e-05 | 71 | 167 | 6 | int:TANGO6 | |
| Interaction | TRRAP interactions | SEL1L FOXO3 MBTD1 DSC1 TCOF1 MYO18A DIDO1 SRCAP KANK2 FSCB FOXR2 ZZZ3 BRCA2 ZNF638 ELF4 MPHOSPH8 PROSER2 VAV2 MRTFA | 3.13e-05 | 790 | 167 | 19 | int:TRRAP |
| Interaction | KIF5B interactions | POU6F2 RNF168 RPAP3 TACC2 RABGAP1 TGOLN2 TRIM16 KIDINS220 TAX1BP1 RNF20 PRKCZ HERC2 | 3.48e-05 | 348 | 167 | 12 | int:KIF5B |
| Interaction | CSNK2A1 interactions | POU6F2 TCOF1 SF3A1 KAT6A USP24 SMARCAD1 E4F1 EFCAB14 KANK2 GTF3C3 LLGL2 INF2 ANKRD11 SMARCC2 MACF1 RPRD2 PRKCZ CTNNA1 SRRM2 GGA1 ZHX1 | 4.42e-05 | 956 | 167 | 21 | int:CSNK2A1 |
| Interaction | ELF4 interactions | 4.89e-05 | 115 | 167 | 7 | int:ELF4 | |
| Interaction | MAD2L1 interactions | SF3A1 KAT6A SMARCAD1 SRCAP ZZZ3 CDC123 BUB1 CHFR MACF1 PPIP5K2 | 4.96e-05 | 252 | 167 | 10 | int:MAD2L1 |
| Interaction | OBSL1 interactions | MAGEA10 TCOF1 SF3A1 PCLO SRCAP KANK2 ADAR TWIST1 SCAF1 CDC123 SYNE2 ASPH ZNF638 SMARCC2 MACF1 CCAR2 CTNNA1 PROSER2 HERC2 SRRM2 | 5.99e-05 | 902 | 167 | 20 | int:OBSL1 |
| Interaction | SEC61B interactions | SEL1L MIA3 RTN3 TACC2 RABGAP1 TGOLN2 LIFR UBE4A KCNQ5 INF2 CDC123 SYNE2 BUB1 ASPH RETREG1 TMEM131 TACC1 PRKCZ | 6.56e-05 | 763 | 167 | 18 | int:SEC61B |
| Interaction | QPRT interactions | 7.05e-05 | 84 | 167 | 6 | int:QPRT | |
| Interaction | MORF4L2 interactions | 8.13e-05 | 168 | 167 | 8 | int:MORF4L2 | |
| Interaction | SOSTDC1 interactions | 9.19e-05 | 29 | 167 | 4 | int:SOSTDC1 | |
| Interaction | SSR1 interactions | MIA3 PSMC4 RTN3 TGOLN2 CHCHD4 KCNQ5 INF2 CDC123 SYNE2 RETREG1 TMEM131 TACC1 CAPRIN1 | 1.07e-04 | 453 | 167 | 13 | int:SSR1 |
| Interaction | RHOC interactions | ROCK2 RNF168 MFSD6 NDFIP2 C2CD2 KIDINS220 INF2 CDC123 SYNE2 RETREG1 MACF1 TMEM131 TACC1 CTNNA1 VPS13B | 1.09e-04 | 584 | 167 | 15 | int:RHOC |
| Interaction | CLTC interactions | AMPH DSCAM RPAP3 MYO18A WNK1 ADAR ABCC6 GTF2I KIDINS220 CDC123 CCAR2 PRKCZ HERC2 GGA1 AP3D1 MYBL2 | 1.14e-04 | 655 | 167 | 16 | int:CLTC |
| Interaction | RAD17 interactions | 1.17e-04 | 92 | 167 | 6 | int:RAD17 | |
| Interaction | DYNLRB1 interactions | 1.17e-04 | 92 | 167 | 6 | int:DYNLRB1 | |
| Interaction | FOXB1 interactions | 1.35e-04 | 135 | 167 | 7 | int:FOXB1 | |
| Interaction | YEATS4 interactions | 1.42e-04 | 182 | 167 | 8 | int:YEATS4 | |
| Interaction | EFTUD2 interactions | ROCK2 TCOF1 RPAP3 SF3A1 KIF21A USP24 PSMC4 DIDO1 TACC2 SMARCAD1 WNK1 TRIP10 NEK9 GTF2I CDC123 SYNE2 ASPH RNF20 ZNF638 SMARCC2 MACF1 CCAR2 CTNNA1 SRRM2 CAPRIN1 AP3D1 | 1.53e-04 | 1449 | 167 | 26 | int:EFTUD2 |
| Interaction | CLTB interactions | 1.59e-04 | 185 | 167 | 8 | int:CLTB | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ROCK2 FOXO3 AMPH KAT6A USP24 RABGAP1 STIL C2CD2 ZZZ3 KIDINS220 BRCA2 TLE1 SYNE2 ZNF638 MACF1 TMEM131 PPIP5K2 EIF4G3 VPS13B MRTFA | 7.22e-07 | 856 | 169 | 20 | M4500 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_ADVENTITIAL_FIBROBLAST | 6.66e-06 | 71 | 169 | 6 | M45664 | |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN | ROCK2 PIK3AP1 LZTS3 PCLO KAT6A USP24 BAK1 CA14 TRIP10 ABCC6 PRSS36 RABL6 INF2 RNF20 ANKRD11 CTNNA1 SRRM2 | 7.18e-06 | 746 | 169 | 17 | M40863 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 2.31e-05 | 180 | 169 | 8 | M8239 | |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP | 4.71e-05 | 199 | 169 | 8 | M7414 | |
| Coexpression | GSE3982_DC_VS_TH2_DN | 4.71e-05 | 199 | 169 | 8 | M5486 | |
| Coexpression | FORTSCHEGGER_PHF8_TARGETS_DN | SPEG MYO18A BAK1 NDFIP2 TACC2 RABGAP1 C2CD2 AKAP12 OLFML2A INF2 SPON2 RETREG1 TACC1 EIF4G3 TNXB HR | 5.03e-05 | 783 | 169 | 16 | M2488 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | ROCK2 FOXO3 KAT6A USP24 RABGAP1 STIL C2CD2 ZZZ3 TLE1 ZNF638 TMEM131 EIF4G3 | 5.31e-05 | 466 | 169 | 12 | M13522 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | ROCK2 MBTD1 RNF168 KIF21A KAT6A USP24 RTN3 DIDO1 EFCAB14 WNK1 ZKSCAN5 UBE4A ZZZ3 BRCA2 TAX1BP1 SYNE2 RNF20 SMARCC2 MACF1 TMEM131 | 8.23e-08 | 629 | 163 | 20 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | MBTD1 RNF168 KIF21A PCLO KAT6A USP24 RTN3 DIDO1 EFCAB14 SRCAP WNK1 UBE4A NRXN2 TAX1BP1 SYNE2 RNF20 MACF1 RPRD2 SEZ6 | 1.67e-07 | 595 | 163 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | MBTD1 RNF168 RPAP3 KAT6A USP24 DIDO1 EFCAB14 WNK1 ZKSCAN5 RABL6 UBE4A ZZZ3 CEP120 TAX1BP1 RNF20 MACF1 TMEM131 ZHX1 | 3.63e-07 | 564 | 163 | 18 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | RNF168 RPAP3 KIF21A KAT6A RTN3 EFCAB14 ZKSCAN5 UBE4A SYNE2 MACF1 | 3.96e-06 | 203 | 163 | 10 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | ROCK2 RNF168 TCOF1 KIF21A PCLO KAT6A MFSD6 PSMC4 EFCAB14 WNK1 ZKSCAN5 TWIST1 UBE4A SSC5D BRCA2 TAX1BP1 SYNE2 CHFR SMARCC2 MACF1 TMEM131 ST18 | 7.19e-06 | 989 | 163 | 22 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 1.81e-05 | 192 | 163 | 9 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000 | RNF168 KIF21A PCLO KAT6A MFSD6 PSMC4 RTN3 CA14 EFCAB14 GMIP WNK1 ZKSCAN5 PRSS36 UBE4A NRXN2 NCAN SYNE2 MACF1 TACC1 ST18 SEZ6 | 2.03e-05 | 979 | 163 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#2 | 5.87e-05 | 173 | 163 | 8 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K2 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_500 | 6.30e-05 | 129 | 163 | 7 | gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k2_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | POU6F2 RNF168 KIF21A PCLO PSMC4 CA14 ZKSCAN5 TWIST1 UBE4A BRCA2 SYNE2 MACF1 MPHOSPH8 | 1.14e-04 | 492 | 163 | 13 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | ROCK2 POU6F2 RNF168 RPAP3 KIF21A PCLO RTN3 DMBX1 NRXN2 BRCA2 SYNE2 MPHOSPH8 ST18 | 1.28e-04 | 498 | 163 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | ROCK2 RNF168 EFCAB14 WNK1 ZKSCAN5 TWIST1 UBE4A BRCA2 TAX1BP1 SMARCC2 MACF1 TMEM131 | 1.32e-04 | 432 | 163 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | RABGAP1 WNK1 KANK2 MAPK8IP3 ZBTB37 LIFR GTF2I NRK HERC2 CAPRIN1 VPS13B | 1.98e-04 | 385 | 163 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | ROCK2 POU6F2 RPAP3 KIF21A PCLO SMARCAD1 STIL BRCA2 TLE3 BUB1 ANKRD11 ZNF638 MPHOSPH8 | 2.44e-04 | 532 | 163 | 13 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| ToppCell | LA-11._Adipocyte|World / Chamber and Cluster_Paper | 4.91e-07 | 183 | 168 | 8 | b177be283e1553fb1f69a346f1ba79ad00297fa2 | |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 4.91e-07 | 183 | 168 | 8 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 9.24e-07 | 199 | 168 | 8 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.59e-07 | 200 | 168 | 8 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.59e-07 | 200 | 168 | 8 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-4|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 9.59e-07 | 200 | 168 | 8 | 54b18c92daaa3b3368c0c46134b0c27e10c8dbb0 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 9.59e-07 | 200 | 168 | 8 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Inmt_(Inmt)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.27e-06 | 112 | 168 | 6 | 153614f307525af56501ac8f9c357c5f7de7882c | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Inmt_(Inmt)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.27e-06 | 112 | 168 | 6 | ba0bd3a77c4865a71fb92d195cd7459c562b63db | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.27e-06 | 112 | 168 | 6 | f9a796b4b5e227096ab360ca9ec08b1c564ac1eb | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.25e-06 | 183 | 168 | 7 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-06 | 184 | 168 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.71e-06 | 185 | 168 | 7 | 3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-06 | 185 | 168 | 7 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 6.95e-06 | 186 | 168 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_3|Classical_Monocyte / Disease condition and Cell class | 7.71e-06 | 189 | 168 | 7 | 8b6f92ccfffc743c07201bc971b3dc1a6fa14ccc | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_3|COVID-19_Convalescent / Disease condition and Cell class | 7.71e-06 | 189 | 168 | 7 | 732e8dcffcb634ca2968f9170c9c4b31dd5d4206 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 7.71e-06 | 189 | 168 | 7 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.98e-06 | 190 | 168 | 7 | f61e21d53f2f7804ac6e40ab6c7f69838aa94d6a | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-06 | 192 | 168 | 7 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.84e-06 | 193 | 168 | 7 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.84e-06 | 193 | 168 | 7 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.84e-06 | 193 | 168 | 7 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | PSB-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.84e-06 | 193 | 168 | 7 | b7d9c5bed524423e92f01496a9f8fad11b33a3f7 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.84e-06 | 193 | 168 | 7 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.14e-06 | 194 | 168 | 7 | 9709dc95fb6982b6a0467b507845d5bc17252e3e | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.14e-06 | 194 | 168 | 7 | 93b7a9065430740ec31fce4e8c14ffccb498591d | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.14e-06 | 194 | 168 | 7 | 0d2e65b44e3f143971c2fd24c4552f042b049cfa | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.46e-06 | 195 | 168 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.46e-06 | 195 | 168 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-05 | 197 | 168 | 7 | c747c496ac090309b7f8a3e9d840928f12c83f2f | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-05 | 199 | 168 | 7 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-05 | 199 | 168 | 7 | 9c2db0bb94cba71a3cc1827844da090e213e0258 | |
| ToppCell | Control-NK|Control / Disease condition and Cell class | 1.08e-05 | 199 | 168 | 7 | f3316fb97c6065286ffd22a0ad9fe7aa5b3b5650 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.11e-05 | 200 | 168 | 7 | 2022df85df94ab8cbb4e80e3fe9894c01051c5e0 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.11e-05 | 200 | 168 | 7 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.11e-05 | 200 | 168 | 7 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Biopsy_IPF-Mesenchymal-HAS1_High_Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 1.11e-05 | 200 | 168 | 7 | d02e256b5d65a5c982ba5696bc7e077281ca3e24 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.94e-05 | 157 | 168 | 6 | 9665a1375cfd8e9b8781c852686591226c0e0d9a | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.15e-05 | 159 | 168 | 6 | 7ed659163f45e0c4df4782997c0786900c8186c8 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.44e-05 | 169 | 168 | 6 | bb43abad2c049b7f4d307737347290e01b3339a3 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.44e-05 | 169 | 168 | 6 | 5f18e3f40a5b1b167903f37516ec8181e889c7c5 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.44e-05 | 169 | 168 | 6 | 8bfa2d3bb541d02f55d7c95b8fd156c8403befca | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-05 | 172 | 168 | 6 | 7fb31ccbcd0204c3612986a6bc20d57ed6825e9c | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-05 | 172 | 168 | 6 | 2a4614b3d25e8c6b095e6992d8ca35371dcdb5e1 | |
| ToppCell | LV-11._Adipocyte|LV / Chamber and Cluster_Paper | 5.05e-05 | 173 | 168 | 6 | c2d3fcb3de71015d03d14c63450853d2b03ffa71 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.56e-05 | 176 | 168 | 6 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.56e-05 | 176 | 168 | 6 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | RV-11._Adipocyte|World / Chamber and Cluster_Paper | 5.74e-05 | 177 | 168 | 6 | f0edf04930692418953e4f00a917257804ec0ffd | |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | 5.92e-05 | 178 | 168 | 6 | 278bbea5cf8f0589f71675c7a3d00679391b5253 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.92e-05 | 178 | 168 | 6 | cda7695411655bd6d0ba69e5041ca7530a9dad3a | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-05 | 180 | 168 | 6 | f9f8245cbcdea18c15e2976c85b72c6807309787 | |
| ToppCell | PCW_10-12-Neuronal-Neuronal_postreplicative|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.49e-05 | 181 | 168 | 6 | 1aebb62ed4439db444ee9d30688212b86ee3d9ef | |
| ToppCell | PCW_10-12-Neuronal-Neuronal_postreplicative-neuro_NA|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.49e-05 | 181 | 168 | 6 | 6aee2ddee4790250ef3b2ef0038bd9839925c995 | |
| ToppCell | PCW_10-12-Neuronal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.49e-05 | 181 | 168 | 6 | 381b553e2cae65ce6be100662a5f9f963353840c | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-05 | 182 | 168 | 6 | 770ce9f3f4538d0181a0181543841bc964c68274 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-05 | 182 | 168 | 6 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class | 6.69e-05 | 182 | 168 | 6 | 354dcdb01360597f68c4fe157a682aee1c0b8bb1 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-05 | 182 | 168 | 6 | 77ab860e2add49dad0c1ffbfc64278ad499dfbd5 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-05 | 182 | 168 | 6 | 4921c7d5687cc79f896b39753bb621d7e3d2972f | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.11e-05 | 184 | 168 | 6 | 4a9f798c67b9998bffe44242b210cc1e224ff5b1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 184 | 168 | 6 | 278a7ed764c326450cb70e69ed2175980eaf5fe0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 184 | 168 | 6 | 8d86e125257ff1d3af8d90577a8b3f0321eca21c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 7.11e-05 | 184 | 168 | 6 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.55e-05 | 186 | 168 | 6 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-05 | 187 | 168 | 6 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-05 | 187 | 168 | 6 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l14|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.85e-05 | 116 | 168 | 5 | f2bf9599040f43b5ea8724841d7b71c0a859c016 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.00e-05 | 188 | 168 | 6 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.00e-05 | 188 | 168 | 6 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.00e-05 | 188 | 168 | 6 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.00e-05 | 188 | 168 | 6 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | (2)_NK/T-(210)_NKT_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 8.24e-05 | 189 | 168 | 6 | fa72e87e1e8cd7cbddae7b47e19cf90d181820a7 | |
| ToppCell | (2)_NK/T-(21)_NKT_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 8.24e-05 | 189 | 168 | 6 | b37ad24898a14a4a3b2d6cea2637de2471f76e20 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.48e-05 | 190 | 168 | 6 | c95032bb3ee2b3d40fdf48016acb46d6f78a48a6 | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.48e-05 | 190 | 168 | 6 | 2abeb013bb83c578e67dcb985ba44ca63134950b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 8.48e-05 | 190 | 168 | 6 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.48e-05 | 190 | 168 | 6 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | 15-Distal-Mesenchymal-Mesenchyme_SERPINF1-high|Distal / Age, Tissue, Lineage and Cell class | 8.48e-05 | 190 | 168 | 6 | b47472dc9fe6ed99c2365203a3d8a59879e74a70 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.48e-05 | 190 | 168 | 6 | 9b825b2586c7b173ff27fcf2abc5860faf50984a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.48e-05 | 190 | 168 | 6 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.48e-05 | 190 | 168 | 6 | d146af1926474328a7c822bc140c4dda66e1bbfb | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.73e-05 | 191 | 168 | 6 | 5271198116343c07202649889057e5774d7fdde3 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 8.73e-05 | 191 | 168 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.73e-05 | 191 | 168 | 6 | 273c4a757292a9301de0eaeacdec91c9866be229 | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.73e-05 | 191 | 168 | 6 | d1205aab0937f2becfcd239610e9b78fb8a0c886 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.99e-05 | 192 | 168 | 6 | 2bfac6b3956265205ca47d06888851ed68b65999 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.99e-05 | 192 | 168 | 6 | 3a6f2c255da46a0b0f5b657b0f56f3d7798ae85a | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.99e-05 | 192 | 168 | 6 | d525f7f088a53110912600a7c9f6d33b9270d534 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.25e-05 | 193 | 168 | 6 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.25e-05 | 193 | 168 | 6 | 2483bb7f398e4fa0ef09c8bd584ed25703853f03 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.25e-05 | 193 | 168 | 6 | adc9fc94f9ec686a417d08c0b8b7b7ab687afec0 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.25e-05 | 193 | 168 | 6 | 45b5cab4dfeb0ed3b13631db5963740a792b810f | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.51e-05 | 194 | 168 | 6 | bc945450b350f597c3ff910d3a14a533d90086a8 | |
| ToppCell | Mesenchymal_cells-Fibro/Chondro_p.|Mesenchymal_cells / Lineage and Cell class | 9.79e-05 | 195 | 168 | 6 | b95a631d54c6cf85e48e1e638703206aaaebc073 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.79e-05 | 195 | 168 | 6 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | Control-B_naive-8|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.01e-04 | 196 | 168 | 6 | 54074da84000e4749ade8acc542f05a275bf829f | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_CD36+_endothelial_cells|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.03e-04 | 197 | 168 | 6 | 66339b5aae3952f5c484c9dcb0cfb4fbd828d4cb | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.03e-04 | 197 | 168 | 6 | 2b3a56bb1d40bc1284a5931c4e7b373660de5402 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD8+_Tem|COVID-19_Severe / Disease group, lineage and cell class | 1.03e-04 | 197 | 168 | 6 | f0bac4d5c3160933ac3786cec8dadffb35d711ea | |
| Computational | Neighborhood of ERBB2IP | 6.19e-05 | 65 | 114 | 6 | GCM_ERBB2IP | |
| Computational | Neighborhood of DEAF1 | 2.02e-04 | 28 | 114 | 4 | GCM_DEAF1 | |
| Drug | Cefotaxime sodium salt [64485-93-4]; Down 200; 8.4uM; MCF7; HT_HG-U133A | MBTD1 RPGRIP1L DSCAM KAT6A GMIP RGP1 NEK9 KIDINS220 INF2 ASPH HR | 2.40e-07 | 197 | 167 | 11 | 2235_DN |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | FOXJ2 TCOF1 DIDO1 TRIP10 RABL6 TLE1 ELF4 PPIP5K2 AP3D1 VPS13B | 1.86e-06 | 195 | 167 | 10 | 6927_DN |
| Drug | Karakoline [39089-30-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A | DSC1 LZTS3 PCLO C2orf72 GTF2I SPON2 BUB1 METTL16 DMP1 VPS13B | 1.86e-06 | 195 | 167 | 10 | 4763_UP |
| Drug | Naphazoline hydrochloride [550-99-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 2.04e-06 | 197 | 167 | 10 | 4949_UP | |
| Drug | Talampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; PC3; HT_HG-U133A | 2.23e-06 | 199 | 167 | 10 | 7254_DN | |
| Drug | Mianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 1.12e-05 | 189 | 167 | 9 | 2231_UP | |
| Drug | Remoxipride Hydrochloride [73220-03-8]; Down 200; 9.8uM; HL60; HT_HG-U133A | 1.33e-05 | 193 | 167 | 9 | 3124_DN | |
| Drug | Quinidine hydrochloride monohydrate [6151-40-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.44e-05 | 195 | 167 | 9 | 3191_DN | |
| Drug | Amprolium hydrochloride [137-88-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 1.50e-05 | 196 | 167 | 9 | 4825_UP | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.56e-05 | 197 | 167 | 9 | 3838_DN | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; HL60; HT_HG-U133A | 1.56e-05 | 197 | 167 | 9 | 2544_DN | |
| Drug | Nimesulide [51803-78-2]; Down 200; 13uM; MCF7; HT_HG-U133A | 1.56e-05 | 197 | 167 | 9 | 2275_DN | |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; PC3; HT_HG-U133A | 1.63e-05 | 198 | 167 | 9 | 4592_DN | |
| Drug | Pepstatin A [26305-03-3]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 1.69e-05 | 199 | 167 | 9 | 3264_UP | |
| Drug | Proglumide [6620-60-6]; Down 200; 12uM; PC3; HT_HG-U133A | 1.69e-05 | 199 | 167 | 9 | 3780_DN | |
| Drug | Letrozole [112809-51-5]; Down 200; 14uM; MCF7; HT_HG-U133A | 1.76e-05 | 200 | 167 | 9 | 7336_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 3.79e-05 | 170 | 167 | 8 | 1050_DN | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 5.25e-05 | 178 | 167 | 8 | 3998_DN | |
| Drug | 15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A | 7.43e-05 | 187 | 167 | 8 | 1656_DN | |
| Drug | chrysene | ROCK2 LZTS3 TCOF1 RTN3 DIDO1 CA14 TACC2 AKAP12 SMTNL1 SPON2 SYNE2 ASPH RNF20 PROSER2 EIF4G3 SRRM2 TNXB HR | 7.56e-05 | 871 | 167 | 18 | ctd:C031180 |
| Drug | Ethotoin [86-35-1]; Down 200; 19.6uM; PC3; HT_HG-U133A | 7.71e-05 | 188 | 167 | 8 | 4545_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 8.00e-05 | 189 | 167 | 8 | 1045_DN | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 8.30e-05 | 190 | 167 | 8 | 2619_DN | |
| Drug | Kawain [500-64-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A | 8.30e-05 | 190 | 167 | 8 | 2299_DN | |
| Drug | thapsigargin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.61e-05 | 191 | 167 | 8 | 7100_DN | |
| Drug | Hexetidine [141-94-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 8.93e-05 | 192 | 167 | 8 | 3318_DN | |
| Drug | radicicol; Up 200; 0.1uM; HL60; HG-U133A | 9.26e-05 | 193 | 167 | 8 | 544_UP | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 9.59e-05 | 194 | 167 | 8 | 4281_DN | |
| Drug | Gentamicine sulfate [1405-41-0]; Down 200; 2.6uM; MCF7; HT_HG-U133A | 9.94e-05 | 195 | 167 | 8 | 2245_DN | |
| Drug | Bromperidol [10457-90-6]; Down 200; 9.6uM; HL60; HG-U133A | 9.94e-05 | 195 | 167 | 8 | 1723_DN | |
| Drug | Progesterone [57-83-0]; Up 200; 12.8uM; HL60; HT_HG-U133A | 9.94e-05 | 195 | 167 | 8 | 2426_UP | |
| Drug | 6-mercaptopurine monohydrate; Down 200; 100uM; MCF7; HG-U133A | 1.03e-04 | 196 | 167 | 8 | 334_DN | |
| Drug | Pentamidine isethionate [140-64-7]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 1.03e-04 | 196 | 167 | 8 | 2834_DN | |
| Drug | Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.03e-04 | 196 | 167 | 8 | 7357_DN | |
| Drug | Deferoxamine mesylate [138-14-7]; Down 200; 6uM; MCF7; HT_HG-U133A | 1.03e-04 | 196 | 167 | 8 | 3842_DN | |
| Drug | genistein; Up 200; 10uM; MCF7; HT_HG-U133A | 1.03e-04 | 196 | 167 | 8 | 5232_UP | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 1.03e-04 | 196 | 167 | 8 | 1662_DN | |
| Drug | Austricine [10180-88-8]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 1.07e-04 | 197 | 167 | 8 | 2812_DN | |
| Drug | Harmaline hydrochloride dihydrate [6027-98-1]; Down 200; 14uM; PC3; HT_HG-U133A | 1.07e-04 | 197 | 167 | 8 | 6623_DN | |
| Drug | Bumetanide [28395-03-1]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.07e-04 | 197 | 167 | 8 | 7440_DN | |
| Drug | SC-58125; Up 200; 10uM; HL60; HG-U133A | 1.07e-04 | 197 | 167 | 8 | 542_UP | |
| Drug | Clomipramine hydrochloride [17321-77-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.07e-04 | 197 | 167 | 8 | 3182_DN | |
| Drug | Retinoic acid [302-79-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.07e-04 | 197 | 167 | 8 | 3165_DN | |
| Drug | Diethylcarbamazine citrate [1642-54-2]; Down 200; 10.2uM; HL60; HT_HG-U133A | 1.11e-04 | 198 | 167 | 8 | 2394_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 1.11e-04 | 198 | 167 | 8 | 2312_UP | |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.11e-04 | 198 | 167 | 8 | 4367_DN | |
| Drug | Hydroquinine hydrobromide hydrate [304695-81-6]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 1.11e-04 | 198 | 167 | 8 | 6263_UP | |
| Drug | Tremorine dihydrochloride [300-68-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.11e-04 | 198 | 167 | 8 | 3196_DN | |
| Drug | Spironolactone [52-01-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.11e-04 | 198 | 167 | 8 | 2226_DN | |
| Drug | Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.14e-04 | 199 | 167 | 8 | 3344_DN | |
| Drug | Dacarbazine [4342-03-4]; Down 200; 22uM; MCF7; HT_HG-U133A | 1.14e-04 | 199 | 167 | 8 | 2754_DN | |
| Drug | Tetrahydrozoline hydrochloride [522-48-5]; Down 200; 16.8uM; MCF7; HT_HG-U133A | 1.14e-04 | 199 | 167 | 8 | 6069_DN | |
| Drug | Thiorphan [76721-89-6]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.14e-04 | 199 | 167 | 8 | 6249_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.14e-04 | 199 | 167 | 8 | 4526_DN | |
| Drug | Arcaine sulfate [14923-17-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 1.14e-04 | 199 | 167 | 8 | 3349_DN | |
| Drug | Amethopterin (R,S) [59-05-2]; Up 200; 8.8uM; PC3; HT_HG-U133A | 1.14e-04 | 199 | 167 | 8 | 6654_UP | |
| Drug | Scopolamine hydrochloride [55-16-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.14e-04 | 199 | 167 | 8 | 4803_DN | |
| Drug | Dihydrostreptomycin sulfate [5490-27-7]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 1.14e-04 | 199 | 167 | 8 | 2237_DN | |
| Drug | Maprotiline hydrochloride [10347-81-6]; Down 200; 12.8uM; PC3; HT_HG-U133A | 1.18e-04 | 200 | 167 | 8 | 6676_DN | |
| Drug | Phenindione [83-12-5]; Up 200; 18uM; MCF7; HT_HG-U133A | 1.18e-04 | 200 | 167 | 8 | 5991_UP | |
| Drug | truxene | 1.60e-04 | 3 | 167 | 2 | CID000068355 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; HL60; HT_HG-U133A | 1.83e-04 | 160 | 167 | 7 | 6133_DN | |
| Disease | Malignant neoplasm of breast | ANK2 TACC2 MAGEE1 WNK1 ADAR FSCB AKAP12 BMP2 MFAP5 LLGL2 TXNDC15 BRCA2 TLE3 TAX1BP1 SYNE2 ANKRD30A MACF1 HERC2 GGA1 VPS13B | 2.62e-06 | 1074 | 165 | 20 | C0006142 |
| Disease | Colorectal Carcinoma | ANK2 TCOF1 SF3A1 WNK1 ABCC6 AKAP12 LIFR BMP2 ZZZ3 KCNQ5 SH3TC1 BUB1 PRKCZ IQUB HR | 1.03e-05 | 702 | 165 | 15 | C0009402 |
| Disease | Neuropathy, Hereditary Sensory And Autonomic, Type IIA | 1.85e-04 | 4 | 165 | 2 | C2752089 | |
| Disease | Hereditary sensory and autonomic neuropathy type 2 | 1.85e-04 | 4 | 165 | 2 | cv:C5574675 | |
| Disease | Neuropathy, hereditary sensory and autonomic, type 2A | 1.85e-04 | 4 | 165 | 2 | cv:C2752089 | |
| Disease | NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA | 1.85e-04 | 4 | 165 | 2 | 201300 | |
| Disease | BRACHYDACTYLY, TYPE A2 | 1.85e-04 | 4 | 165 | 2 | C1832702 | |
| Disease | multiple myeloma | 4.26e-04 | 112 | 165 | 5 | EFO_0001378 | |
| Disease | stearoyl sphingomyelin (d18:1/18:0) measurement | 4.59e-04 | 6 | 165 | 2 | EFO_0800611 | |
| Disease | Nephroblastoma | 8.51e-04 | 8 | 165 | 2 | cv:C0027708 | |
| Disease | Hereditary Wilms tumor | 8.51e-04 | 8 | 165 | 2 | cv:C0677779 | |
| Disease | Kidney Wilms tumor | 8.51e-04 | 8 | 165 | 2 | cv:CN305775 | |
| Disease | PR segment | 1.36e-03 | 10 | 165 | 2 | EFO_0005095 | |
| Disease | microfibrillar-associated protein 2 measurement | 1.65e-03 | 11 | 165 | 2 | EFO_0801801 | |
| Disease | nevus count, cutaneous melanoma | 1.73e-03 | 91 | 165 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 1.80e-03 | 43 | 165 | 3 | DOID:2476 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 1.87e-03 | 93 | 165 | 4 | C1535926 | |
| Disease | sunburn | 2.10e-03 | 96 | 165 | 4 | EFO_0003958 | |
| Disease | testosterone measurement | DCHS2 MIA3 ANK2 DSCAM SRCAP ADAR ZKSCAN5 C2CD2 UBE4A GTF2I TXNDC15 CEP120 KCNQ5 SYNE2 MACF1 METTL16 | 2.19e-03 | 1275 | 165 | 16 | EFO_0004908 |
| Disease | extracellular matrix protein 1 measurement | 2.33e-03 | 13 | 165 | 2 | EFO_0008126 | |
| Disease | Hereditary Motor and Sensory-Neuropathy Type II | 2.33e-03 | 13 | 165 | 2 | C0270914 | |
| Disease | squamous cell lung carcinoma | 2.40e-03 | 165 | 165 | 5 | EFO_0000708 | |
| Disease | nephroblastoma (is_implicated_in) | 2.71e-03 | 14 | 165 | 2 | DOID:2154 (is_implicated_in) | |
| Disease | disease recurrence, colon carcinoma | 2.94e-03 | 51 | 165 | 3 | EFO_0004952, EFO_1001950 | |
| Disease | blood phosphate measurement | 3.02e-03 | 174 | 165 | 5 | EFO_0010972 | |
| Disease | Myopia | 3.11e-03 | 15 | 165 | 2 | C0027092 | |
| Disease | Synostotic Posterior Plagiocephaly | 3.54e-03 | 16 | 165 | 2 | C1833340 | |
| Disease | Craniosynostosis, Type 1 | 3.54e-03 | 16 | 165 | 2 | C4551902 | |
| Disease | Acrocephaly | 3.54e-03 | 16 | 165 | 2 | C0030044 | |
| Disease | Trigonocephaly | 3.54e-03 | 16 | 165 | 2 | C0265535 | |
| Disease | Scaphycephaly | 3.54e-03 | 16 | 165 | 2 | C0265534 | |
| Disease | Synostotic Anterior Plagiocephaly | 3.54e-03 | 16 | 165 | 2 | C2931150 | |
| Disease | Metopic synostosis | 3.54e-03 | 16 | 165 | 2 | C1860819 | |
| Disease | Intellectual Disability | 3.79e-03 | 447 | 165 | 8 | C3714756 | |
| Disease | FEV/FEC ratio | FOXO3 DCHS2 SPEG ZNF184 TWIST1 LLGL2 GTF2I KCNQ5 BRDT CDC123 SYNE2 ANKRD11 TNXB AP3D1 MRTFA | 3.85e-03 | 1228 | 165 | 15 | EFO_0004713 |
| Disease | Brachycephaly | 4.00e-03 | 17 | 165 | 2 | C0221356 | |
| Disease | cortical thickness | FOXO3 TACC2 SMARCAD1 RABGAP1 LRCH1 MAPK8IP3 BMP2 CEP120 MACF1 TMEM131 TACC1 PRKCZ EIF4G3 ST18 | 4.02e-03 | 1113 | 165 | 14 | EFO_0004840 |
| Disease | vital capacity | FOXO3 POU6F2 PCLO ZNF184 MFSD6 TWIST1 LLGL2 CEP120 KCNQ5 CDC123 CCAR2 RPRD2 ELF4 PROSER2 TNXB | 4.08e-03 | 1236 | 165 | 15 | EFO_0004312 |
| Disease | basal cell carcinoma | 4.30e-03 | 189 | 165 | 5 | EFO_0004193 | |
| Disease | serum non-albumin protein measurement | 4.33e-03 | 361 | 165 | 7 | EFO_0004568 | |
| Disease | Meckel syndrome type 1 | 4.48e-03 | 18 | 165 | 2 | C3714506 | |
| Disease | cutaneous melanoma | 4.82e-03 | 121 | 165 | 4 | EFO_0000389 | |
| Disease | forced expiratory volume | POU6F2 DSCAM ZNF184 STIL TWIST1 SSC5D LLGL2 CEP120 CDC123 RPRD2 TNXB | 4.99e-03 | 789 | 165 | 11 | EFO_0004314 |
| Disease | skin sensitivity to sun | 4.99e-03 | 19 | 165 | 2 | EFO_0004795 | |
| Disease | gamma-aminoisobutyric acid measurement | 4.99e-03 | 19 | 165 | 2 | EFO_0010482 | |
| Disease | cutaneous melanoma, hair color | 5.10e-03 | 62 | 165 | 3 | EFO_0000389, EFO_0003924 | |
| Disease | pulse pressure measurement | FOXO3 ANK2 DSCAM RABGAP1 SRCAP LRCH1 NEK9 TWIST1 CEP120 KCNQ5 CDC123 ANKRD11 ZNF638 DDHD2 ST18 AP3D1 | 5.12e-03 | 1392 | 165 | 16 | EFO_0005763 |
| Disease | phosphatidylcholine measurement | 5.40e-03 | 284 | 165 | 6 | EFO_0010226 | |
| Disease | Craniosynostosis | 5.53e-03 | 20 | 165 | 2 | C0010278 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DSEGNFETPEAETPI | 56 | O75410 | |
| TEPTEQAPDALEQAA | 461 | Q8N163 | |
| EEEDAPSFAPSSSVD | 301 | Q6UB99 | |
| ALPPDLDTSEDQQAT | 1906 | Q6UB99 | |
| TDTDAAIAEDPPDAI | 701 | O43683 | |
| QSQSSTEDPKDEPAE | 521 | Q5VTR2 | |
| SSAQEDFQEPEEELP | 246 | A6NCS6 | |
| EPALPSASEEQVAQD | 16 | Q16611 | |
| EPSLSNSNPDEIEID | 541 | Q58F21 | |
| ANEDDSDVPAVVPLS | 836 | Q02952 | |
| IDPADASPDQEISFS | 476 | A8K2U0 | |
| EQSAEETPREITSPA | 351 | Q9BXX3 | |
| AAPEDADSPQAVDVI | 921 | O94983 | |
| SEQENPDSSEPVVED | 231 | Q12797 | |
| VATEAEFSPEDSPSV | 206 | Q6ZUJ8 | |
| PSSQPSDEVLSEFEL | 41 | P12643 | |
| EAASAPAVEDQVPEA | 261 | Q14444 | |
| SNRPPETADEEQVES | 386 | O75071 | |
| ESAQPEAEELEATVP | 521 | P49418 | |
| PTESDEDIAPAQQVD | 761 | O14617 | |
| IDPSDATPSFEDLVE | 356 | Q7Z5Q5 | |
| AEAAETAEAVSPTPI | 21 | Q13434 | |
| ADENIDVTSNDPEFP | 191 | Q9Y5X4 | |
| PVPSQDITLSSEEEA | 461 | Q3YEC7 | |
| DDSPDSSPEEQKSVI | 3271 | Q01484 | |
| EASSPFTPVADEDSV | 131 | Q9Y3P9 | |
| EEPATEEPTAQEATA | 231 | Q5JQC4 | |
| SVSLVEESQDPSIPE | 276 | Q6TGC4 | |
| STNDASPLDPITEED | 1466 | Q9ULH0 | |
| PAEPQDALATCESDE | 526 | O60299 | |
| QEEEEPSSSVDPAQL | 86 | P43362 | |
| LIPSTPEEVSADDET | 66 | P43363 | |
| EAAAEVPSPDSEVSS | 716 | Q9HCI5 | |
| STEEATEATEVPDPG | 891 | Q9UPT6 | |
| TVLTEADPAATFDDP | 336 | Q6P1M3 | |
| EEEDSQQESETPDPS | 761 | Q8TD19 | |
| SSSEESEEEVAPLPS | 16 | Q05BQ5 | |
| DTAIIPSSNDPQFDD | 826 | Q68CZ1 | |
| DETPAEAQSPLSEET | 536 | Q5H9T9 | |
| EEAPAEVQSLPAEET | 676 | Q5H9T9 | |
| EDEDESSEATAAPPQ | 301 | Q99607 | |
| PTPQSDQREDVAEDT | 826 | Q9P107 | |
| LPAAAQPSAEDSDTE | 1931 | O95714 | |
| ETPSSAELVADDPND | 21 | Q8N4Q1 | |
| TETDTFDAAPQPARE | 881 | Q9NR82 | |
| SIKEETPDSAETPAE | 731 | O43593 | |
| DSVEESSESENSPVP | 1511 | Q9Y6V0 | |
| DLEPPTDDSVAAVDQ | 846 | Q92614 | |
| EETPETTASPIEYQD | 531 | Q14D04 | |
| AEPATLQLDTPVADD | 96 | Q9P2S2 | |
| EPESTSEKPSDVNTE | 621 | O94830 | |
| VETEDPSLEDTSVPS | 446 | Q86UT5 | |
| EEPASLAAAVSNPEE | 1226 | O94854 | |
| ATEPSDEDTVSLNVP | 336 | Q9Y2L9 | |
| QESLSQEENPEPTED | 451 | Q86W50 | |
| SPEQPSASVSLLDDE | 346 | Q9UJY5 | |
| PEPEKDADSINSSID | 171 | Q8TAD2 | |
| PDDDLSQDSPEQEAS | 156 | Q9P0K8 | |
| QPEDSPEAEASTLDV | 386 | Q86VP3 | |
| SLNFSEESPESPEDE | 411 | Q13316 | |
| PSSTETSAIPEEEID | 41 | Q6ZSS7 | |
| EDPELNTPTDVVADA | 871 | Q2PPJ7 | |
| VQTPPDLESSEEVDA | 1166 | P28290 | |
| QDSDPTEANLESADP | 21 | Q27J81 | |
| DDEPQPEVSLEVASD | 406 | Q6NXR0 | |
| TFTEDPNLVNDPATD | 41 | Q13361 | |
| RTSEDEPESSPQDVE | 701 | Q9UMZ3 | |
| DDCSNEVVPVDATPE | 3056 | Q6V1P9 | |
| EPPKELDTASSDEEN | 266 | Q9NQX5 | |
| FQDSALSPTQEEPED | 21 | Q5K4E3 | |
| VSSEETFEPSQELPA | 421 | O15488 | |
| EEDAASSEVPAASPA | 1241 | Q92794 | |
| DSSNSPETETKEPEV | 1256 | Q92794 | |
| TSPEIEAPYTSEEEQ | 556 | Q86VX9 | |
| EEDNSESSAIEQPPT | 111 | Q9NV92 | |
| SFSSLEPQDQEDLEP | 241 | Q96EP1 | |
| ESEASVFIADPPTID | 591 | Q8N9C0 | |
| ASAPPEEAESAQASL | 556 | Q9Y426 | |
| VEAAVEALSSDPAQP | 591 | P35221 | |
| LEPEDSNSTSALEDP | 276 | P55265 | |
| SEVEPNDTDPLDSNV | 356 | P51587 | |
| DDENTATLTAPEFPE | 71 | O75794 | |
| QSPPTKDDATESEVE | 391 | Q8N960 | |
| QSASESAPEDQPDRE | 186 | Q8NFW5 | |
| DTSPAEDNREATLPQ | 6 | Q5TBE3 | |
| DLEDSPPVSDSEEQQ | 801 | Q9BTC0 | |
| DDAFDTVTIPVPSEE | 21 | Q8NA54 | |
| TISLEDENDNPPSFT | 341 | Q08554 | |
| DEAKSPAPETSDLEQ | 541 | Q8N6P7 | |
| EEEAEEPDDNSLQSP | 156 | Q6PJQ5 | |
| ISDNDSTENEAPEPR | 521 | Q63ZY3 | |
| EDSPAAATTVLTEDP | 611 | Q66K89 | |
| ESAEPSQLEVPATEE | 966 | P78347 | |
| SPIDIQTDSVTFDPD | 46 | Q9ULX7 | |
| DFELPEEETTQPDTA | 316 | O75056 | |
| SATPEPVTDNRDVED | 356 | Q5VT52 | |
| ETSDPLPTNENDDDI | 321 | O43432 | |
| SSDEETQSLSEIPDP | 576 | P42702 | |
| SSVLNDSPFPEDDSE | 266 | Q99549 | |
| EPNSAEQDEAEPRSS | 331 | Q68BL7 | |
| EIPESKENGTEPESS | 321 | Q12908 | |
| AEPAQAETEAEEPES | 566 | Q7Z2Y5 | |
| PSNELTITADEAAPD | 971 | O60469 | |
| TELDEVQDDDAPLSP | 331 | O43524 | |
| PDTNVSLEDVSEVAP | 586 | O95197 | |
| DEDAQEETEPSAPSA | 671 | P84550 | |
| SEDSKEDENVPTAPD | 691 | Q86VP1 | |
| RDNEIVDSASVPETP | 261 | Q9BUD6 | |
| SNFESSPEVEERPAV | 1266 | Q9UQ35 | |
| SNALVDVLPPEADSS | 136 | P43686 | |
| EKTEDSSVPETPDNE | 61 | Q9H4L7 | |
| TEEGTTPPIEADTLD | 4201 | Q8WXH0 | |
| TPPIEADTLDSSDAQ | 4206 | Q8WXH0 | |
| SVTEDISFLESPNPE | 86 | Q9UBV2 | |
| TAAEEPASVTPLENA | 1131 | Q5JRA6 | |
| ESDSEEEAPAQAKPS | 416 | Q13428 | |
| DSEDPLVDSAPVTCD | 816 | Q5TCX8 | |
| TSEAQTEVPLDDPDR | 901 | O95255 | |
| QDEAVAPSSPFLEED | 171 | Q92546 | |
| LSQAAPIPEEDTDTE | 436 | Q9H6L5 | |
| ESTSSPSEPEDVIDL | 96 | Q86WR7 | |
| EIPDEKEEATSNSPS | 531 | Q8IZX4 | |
| PEEPSAEDSINNSLV | 331 | P10244 | |
| LLAPVESNDSEDTPS | 46 | P78424 | |
| TPDFQEPLVSSGEEE | 401 | O14594 | |
| VSEDLDQQSLPSEPE | 336 | Q8NC44 | |
| ASSDVSLQDPEEPSF | 471 | Q8TE82 | |
| APAQPSAEDSDTEDD | 661 | Q9BVR0 | |
| SVPSAPEEEEETVAS | 2221 | Q6ZRS2 | |
| EQVPESDTTPDLDTT | 1116 | A1L4H1 | |
| QPTEEEASSKEDSAP | 21 | Q15459 | |
| IPASEIEASVEDAPT | 216 | Q8TAQ2 | |
| DEDSSDALSPEQPAS | 116 | Q969V6 | |
| AQPSFPDVEEEDSES | 271 | O60284 | |
| KLSAEENPDDSEVPS | 41 | Q9Y5Q9 | |
| SQDTKESSEEPPSEE | 506 | Q15642 | |
| TESGEETDLISPPQE | 296 | O43493 | |
| SSDNSEDEEEPPDNA | 1131 | Q15468 | |
| DNLVVDVSNEDPSSP | 246 | Q04724 | |
| LATTVPESAEPEAEA | 411 | Q96CK0 | |
| AEEESPSQEETVAPG | 476 | Q5TC79 | |
| TDIPTEDEALGTPET | 1951 | Q15772 | |
| QSEEASESSSPVPED | 2261 | Q8IWN7 | |
| AEEAEPGSPSEEQEQ | 241 | A8MU46 | |
| TIDVPDSTTAAAPEN | 446 | Q9H6T3 | |
| VPLENVEDSTDEDAP | 1111 | Q7Z4S6 | |
| TPEVSFLPEEATEEA | 1001 | Q9H7N4 | |
| AASPEAEQFPESSEL | 31 | Q969T3 | |
| SSEEEITLENPADVP | 846 | Q92545 | |
| AEEETPSPTELSTEA | 2716 | P22105 | |
| PEVAESDAAPTEDSN | 151 | Q96J42 | |
| PDREEIVENPSSSAS | 216 | Q9UKY1 | |
| ETAAPVVPELSSDID | 366 | O75116 | |
| EETDGELTAAPTPEQ | 36 | Q53EL9 | |
| TESSPVADDIIQPAA | 1856 | O95359 | |
| EQPPRDQTLTSSDEE | 741 | O15040 | |
| QDVESTFSSPEDSLP | 496 | Q96RU2 | |
| SPESSPDQEETEINF | 411 | Q8IYW5 | |
| DDLVVDVSNEDPATP | 246 | Q04726 | |
| QEAEDLSLSAPSSPE | 2061 | Q9UPU5 | |
| PFNTTEDPDISTADL | 2356 | Q7Z7G8 | |
| SPDSGSASPVEEEDV | 31 | O95361 | |
| DELPASPDDSDNSVS | 41 | Q14139 | |
| IRPFPSEETTENDDD | 126 | P52735 | |
| ATNDEESPLSVSSPE | 971 | O43314 | |
| ASVSTQVEPEEPEAD | 621 | Q9H4A3 | |
| QEQEDSEEGETPTDP | 346 | Q9ULD5 | |
| SPADDSLSNSEEEPD | 11 | Q15672 | |
| EAPNSSEEDSPIKSD | 126 | Q8IYH5 | |
| SPIDESEVQTATDSP | 1106 | Q14966 | |
| ENSVSAPEPDISEEE | 106 | Q99676 | |
| DLDPPAETSQEQEDL | 11 | Q9Y2L8 | |
| TERSVPQDPDFAEVS | 286 | Q9Y2L8 | |
| NPTESEKPDTSAESD | 1796 | Q9P2D8 | |
| EKPDTSAESDTEQNP | 1801 | Q9P2D8 | |
| VVEAPSASETAEEPL | 691 | Q9P206 | |
| QFTSEPVQLTPDDED | 551 | Q05513 |